Catalyst
Slingshot members are tracking this event:
Aduro Biotech (ADRO) ADU-S100, a treatment for multiple tumors, expecting Phase 1 monotherapy data in the second half of 2017
- Source Link:
- https://seekingalpha.com/filing/3351398
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 17, 2018
Occurred Source:
http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2343034
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Adu-s100, Multiple Tumors, Phase 1 Monotherapy
